Currently, no medication has been proven effective in reducing neuroinflammatory and cerebral microvascular effects resulting from MetS
Certain groups face elevated risk of B12 deficiency and should discuss testing with their healthcare provider: Individuals following vegan or strict vegetarian diets without adequate supplementation Older adults (particularly those over 60 years), due to reduced gastric acid production People with gastrointestinal conditions including Crohn's disease, coeliac disease, or those who have undergone gastric or ileal surgery Long-term users of medications affecting B12 absorption, such as metformin (MHRA advises monitoring B12 levels), PPIs, or H2-receptor antagonists Individuals with pernicious anaemia or family history of this autoimmune condition People with exposure to nitrous oxide (recreational or occupational), which can cause functional B12 deficiency Diagnostic testing typically involves serum B12 measurement , though this may not always reflect tissue stores accurately
Currently, 340 million people are suffering globally and it is estimated that, by 2030, it would be the seventh leading cause of mortality 1 Microvascular complications associated with diabetes leads to organ loss and both stroke and heart disease related mortality is 24 times higher in diabetics than in normal individuals 2
Yes, restarting weight loss medications after discontinuation is a reasonable medical decision that should be discussed with your healthcare provider
Development and validation of a genetic algorithm for flexible docking
